Bacillus Coagulans Market by Type (Type 1, Type 2, and Type 3) and Application (Food, Drugs, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Report Number: 5012
  • Publish Date: 24-May-2018

Reports Overview

Bacillus coagulans is beneficial bacteria used correspondingly to lactobacillus and other probiotics. It is used for treatment of diarrhea, including infectious types such as traveler’s diarrhea, rotaviral diarrhea in children, and diarrhea caused by antibiotics. In addition, it used for the treatment of irritable bowel syndrome (IBS), general digestion problems, inflammatory bowel disease (IBD, Crohn’s disease, and ulcerative colitis), and infection due to ulcer-causing bacterium Helicobacter pylori. It is used to improve the immune system to prevent respiratory infections and cancer or the formation of cancer-causing agents.
 
The global Bacillus coagulans market has witnessed significant growth opportunities, owing to increase in health concerns around the world and rise in demand for functional foods. In addition, rise in investments on R&D activities propel the market growth. However, lack of awareness among consumers about the effectiveness of Bacillus coagulans restrains the market growth. Rise in demand for Bacillus coagulans products in emerging economies is expected to provide growth opportunities for the market.

The global Bacillus coagulans market is segmented based on type, application, and geography. On the basis of type, the market is categorized into type 1, type 2, and type 3. Applications covered in the study include food, drugs, and others. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major players operating in the global market are focusing on key market strategies such as mergers, acquisitions, collaborations, and partnerships.

Some of the key players in the global market include:

  • Ganeden
  • Sabinsa Corporation
  • Mitsubishi
  • Nebraska Cultures Inc.
  • Syngen Biotech Co.
  • Microbax
  • Unique Biotech
  • Aumgene Biosciences
  • Mystical Biotec
  • Sanzyme

Key Benefits

  • This report provides a quantitative analysis of the current trends, estimations, and dynamics from 2016 to 2023 to assist to identify the prevailing market opportunities.
  • Major countries in each region are mapped according to the individual market revenue.
  • The region-wise and country-wise market conditions are comprehensively analyzed.
  • This study evaluates the competitive landscape and the value chain analysis to understand the competitive environment across geographies.
  • An in-depth analysis of each segment is provided to assist the prevailing market opportunities.

Bacillus Coagulans Market Key Segments:

By Type

  • Type 1
  • Type 2
  • Type 3

By Application

  • Food
  • Drugs
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • South Africa
    • Rest of LAMEA

Table of Content

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 GLOBAL BACILLUS COAGULANS MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. TYPE 1

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. TYPE 2

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. TYPE 3

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

Chapter: 5 GLOBAL BACILLUS COAGULANS MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. FOOD

5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast

5.3. DRUGS

5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast

5.4. OTHERS

5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast

Chapter: 6 GLOBAL BACILLUS COAGULANS MARKET, BY GEOGRAPHY

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. By Type
6.2.3.2. By Application

6.2.4. U.S.

6.2.4.1. Market size and forecast, by Type
6.2.4.2. Market size and forecast, by Application

6.2.5. Canada

6.2.5.1. Market size and forecast, by Type
6.2.5.2. Market size and forecast, by Application

6.2.6. Mexico

6.2.6.1. Market size and forecast, by Type
6.2.6.2. Market size and forecast, by Application

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. By Type
6.3.3.2. By Application

6.3.4. Germany

6.3.4.1. Market size and forecast, by Type
6.3.4.2. Market size and forecast, by Application

6.3.5. France

6.3.5.1. Market size and forecast, by Type
6.3.5.2. Market size and forecast, by Application

6.3.6. UK

6.3.6.1. Market size and forecast, by Type
6.3.6.2. Market size and forecast, by Application

6.3.7. Italy

6.3.7.1. Market size and forecast, by Type
6.3.7.2. Market size and forecast, by Application

6.3.8. Russia

6.3.8.1. Market size and forecast, by Type
6.3.8.2. Market size and forecast, by Application

6.3.9. Rest of Europe

6.3.9.1. Market size and forecast, by Type
6.3.9.2. Market size and forecast, by Application

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. By Type
6.4.3.2. By Application

6.4.4. China

6.4.4.1. Market size and forecast, by Type
6.4.4.2. Market size and forecast, by Application

6.4.5. Japan

6.4.5.1. Market size and forecast, by Type
6.4.5.2. Market size and forecast, by Application

6.4.6. India

6.4.6.1. Market size and forecast, by Type
6.4.6.2. Market size and forecast, by Application

6.4.7. South Korea

6.4.7.1. Market size and forecast, by Type
6.4.7.2. Market size and forecast, by Application

6.4.8. Rest of Asia-Pacific

6.4.8.1. Market size and forecast, by Type
6.4.8.2. Market size and forecast, by Application

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. By Type
6.5.3.2. By Application

6.5.4. Brazil

6.5.4.1. Market size and forecast, by Type
6.5.4.2. Market size and forecast, by Application

6.5.5. Argentina

6.5.5.1. Market size and forecast, by Type
6.5.5.2. Market size and forecast, by Application

6.5.6. South Africa

6.5.6.1. Market size and forecast, by Type
6.5.6.2. Market size and forecast, by Application

6.5.7. Rest of LAMEA

6.5.7.1. Market size and forecast, by Type
6.5.7.2. Market size and forecast, by Application

Chapter: 7 COMPANY PROFILES

7.1. GANDENE

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. SABINSA CORPORATION

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. MITSUBISHI

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. NEBRASKA CULTURES INC.

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. SYNGEN BIOTECH CO.

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. MICROBAX

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. UNIQUE BIOTECH

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. AUMGENE BIOSCIENCES

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. MYSTICAL BIOTECH

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. SANZYME

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

There are no reviews yet.

Be the first to review “Bacillus Coagulans Market Opportunity Analysis and Industry Forecast”